Skip to content

Virtual reality-assisted cognitive behavioral therapy improves the theory of mind and decreases paranoia in patients with schizophrenia

VR-assisted cognitive behavioral therapy in patients with schizophrenia who experience paranoia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14425939
Enrollment
40
Registered
2023-12-28
Start date
2023-12-10
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paranoid schizophrenia Mental and Behavioural Disorders

Interventions

This study will be an open-label, randomized, controlled trial that will be conducted in the ARAS investigation phase of acute-onset psychosis. ARAS is a prospective group of the first episode of psyc

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A diagnosis of paranoid schizophrenia 2. Aged 18 years old and over

Exclusion criteria

Exclusion criteria: 1. Psychosis caused by organic causes defined in ARAS 2. Substance use 3. Lower than normal IQ 4. Patients who do not cooperate with the completion of treatment sessions

Design outcomes

Primary

MeasureTime frame
The factors of paranoid thoughts from the aspect of suspicion and mistrust (related to thoughts of being harmed by others, being under control and feeling insecure) measured using the standard Positive and Negative Syndrome Scale (PANSS) for Schizophrenia at baseline and 1 week later

Secondary

MeasureTime frame
The acceptance rate of VR and its usability will be measured using the relevant questionnaire at the end of intervention

Countries

Iran

Contacts

Public ContactElham;Elham Monaghesh;Monaghesh

;

monaghghesh1997@gmail.com;dabirkhanecent@tbzmed.ac.ir+989149896585;+989149896585

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026